Psoriatic Arthritis Research Collaborative: Biologic Sub-Study (PARC-B)

Recruiting

18 years - 89 years

All

Phase N/A

55 participants needed

1 Location

Brief description of study

This study will help researchers better understand the management of psoriatic arthritis (PsA). The goals of this study are a) to better understand how PsA responds to biologic therapy b) to build a registry of data and blood from patients with PsA for future studies and c) to figure out how to best measure disease activity and quality of life for those with PsA. To be eligible, patients must have a psoriatic arthritis and starting a TNFi (etanercept, adalimumab, infliximab, certolizumab, or golimumab). This study will last about 3 months and will include 2 study visits. The doctor will ask questions about your health, do a physical exam, and get a blood sample. Information from these activities will be entered into a scientific database. Information that could identify you will not be included.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Psoriatic arthritis
Age: 18 years - 89 years
Gender: All

Updated on 19 Feb 2024. Study ID: 828357

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).